# Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years

> **NCT03582254** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 62 (actual)

## Conditions studied

- Primary Central Nervous System Lymphoma

## Interventions

- **RADIATION:** [18F]-FDG PET/MR

## Key facts

- **NCT ID:** NCT03582254
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06-13
- **Primary completion:** 2021-05-12
- **Final completion:** 2023-05-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582254, "Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03582254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*